Results 191 to 200 of about 111,447 (309)

Oral antihypertensive agents and diuretics in the management of hypertension in postpartum women: a systematic review and meta-analysis. [PDF]

BMJ Open
Hup RJ, Paauw ND, Lely AT, Depmann M.
europepmc   +1 more source

Therapeutic Potentials of Selected Antihypertensive Agents and Their Fixed-Dose Combinations Against Trastuzumab-Mediated Cardiotoxicity. [PDF]

Front Pharmacol, 2020
Olorundare OE, Adeneye AA, Akinsola AO, Ajayi AM, Agede OA, Soyemi SS, Mgbehoma AI, Okoye II, Albrecht RM, Ntambi JM, Crooks PA.   +10 more
europepmc   +1 more source

Association of Weight Loss Composition Following Metabolic‐Bariatric Surgery With Incident Major Adverse Cardiovascular Events and All‐Cause Mortality

Clinical Obesity, EarlyView.
ABSTRACT Severe obesity is associated with an increased cardiovascular risk. Metabolic‐bariatric surgery (MBS) can reduce the risk of cardiovascular events and mortality, potentially depending on weight loss composition. This study assessed the association between post‐MBS weight loss composition and major adverse cardiovascular events (MACE) and all ...
Malou A. H. Nuijten, Bente M. de Roos, Jan H. M. Karregat, Eric J. Hazebroek, Valerie M. Monpellier, Ignace M. C. Janssen, Maria T. E. Hopman, Esmée A. Bakker, Thijs M. H. Eijsvogels   +8 more
wiley   +1 more source

Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta-analysis. [PDF]

Pharmacol Res Perspect
Érszegi A, Viola R, Bahar MA, Tóth B, Fejes I, Vágvölgyi A, Csupor D.   +6 more
europepmc   +1 more source

Pharmacological properties of 3-(2-chlorophenyl)-6-ethoxycarbonyl-5,7-dimethyl-2-(N-methylcarbamoyloxymethyl)-4(3H)-quinazolinone (EG1088), a novel antihypertensive agent (II)

, 1982
Hiroshi Azuma, Yoshimi Takashima, Yasuhiro Katsuura, Masayuki Ishikawa, Soyao Moriguchi, Hisashi Ebisawa   +5 more
openalex   +1 more source

Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort

Diabetic Medicine, EarlyView.
Abstract Aims This study assesses national trends and, socio‐demographic and clinical factors associated with polypharmacy and potentially in appropriate prescribing among people with type 2 diabetes in Scotland from 2012 to 2022. Methods Retrospective cohort study using nationwide data from the Scottish Care Information – Diabetes database ...
William Berthon, Stuart J. McGurnaghan, Luke A. K. Blackbourn, Amanda de Assuncao Santiago Fernandes, Lauren E. Walker, Rory J. McCrimmon, Helen M. Colhoun, David A. McAllister, Peter Hanlon   +8 more
wiley   +1 more source

Real‐world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim A retrospective observational cohort study, in the Netherlands, evaluated clinical outcomes with oral semaglutide. Methods Glucagon‐like peptide‐1 receptor agonists (GLP‐1ra) naïve type 2 diabetes (T2D) patients who initiated oral semaglutide between 1 January 2020 and 31 December 2022 were identified from the PHARMO Data Network.
Abigail Postema, Jordy Gaspersz, Brenda N. Baak, Eline L. Huisman, Charlotte Hoogstraten, Lise Meinicke Hagelund, Fernie J. A. Penning‐van Beest, Jetty A. Overbeek   +7 more
wiley   +1 more source

Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: A novel target for antihypertensive agents

, 2011
Kafait U. Malik, Brett L. Jennings, Fariborz A. Yaghini, Seyhan Şahan-Fırat, Chi Young Song, Anne M. Estes, Xiao Fang   +6 more
openalex   +2 more sources

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the lipid‐lowering efficacy, safety, and adherence of switching from moderate‐ or low‐intensity statin monotherapy to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus (T2DM) and dyslipidaemia.
Sangmo Hong, Won J. Kim, Sungrae Kim, Jung H. Park, Eun S. Kang, Min K. Moon, Jae T. Kim, Ji‐Oh Mok, Ki Y. Lee, Cheol‐Young Park, Chang B. Lee   +10 more
wiley   +1 more source

Factors associated with adherence to antihypertensive agents in the older adult. [PDF]

Rev Cuid
Silva Fhon JR, Gómez-Luján MDP, Caetano GM, Cáceda-Ñazco GS, Pereira Dos Santos-Neto A, Leitón-Espinoza ZE.   +5 more
europepmc   +1 more source